Turning Point Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Turning Point Therapeutics, Inc.
CIK #0001595893
EDGAR Form CIK 2011 - 2025
10-K [0001595893]
10-Q [0001595893]
3 [0001595893]
4 [0001595893]
8-K [0001595893]
D [0001595893]
SC 13D [0001595893]
SC 13G [0001595893]
Form 13D/13G Filer Form 13D/13G Subject Filed
Cormorant Asset Management LP Turning Point Therapeutics Inc [2022-02-14]
Wellington Management Group LLP Turning Point Therapeutics Inc [2022-02-04]
Price T Rowe Associates Inc /MD/ Turning Point Therapeutics Inc [2021-02-16]
Vanguard Group Inc Turning Point Therapeutics Inc [2020-02-11]
BlackRock Inc Turning Point Therapeutics Inc [2020-02-07]
CUI Jingrong Jean Turning Point Therapeutics Inc [2020-02-05]
FMR LLC Turning Point Therapeutics Inc [2019-08-12]
Foresite Capital Fund IV LP Turning Point Therapeutics Inc [2019-05-02]
GlaxoSmithKline PLC Turning Point Therapeutics Inc [2019-04-26]
Cormorant Asset Management LP Turning Point Therapeutics Inc [2019-04-25]
View All
Form 3/4/5 Subject 2011 - 2025
Turning Point Therapeutics, Inc.
Countouriotis Athena
Nicholson Garry A
Machado Patrick
George Simeon
Gallagher Carol Giltner
Bodem Barbara W.
Alles Mark J
Tombesi Paolo
Sun Brian
Sabus Steve M
Hirmand Mohammad
Reich Siegfried
Partridge Andrew John
North Annette
Van Hoose Kyri K.
Baker Brian Lee
Larson Yi
Gordon Carl L
Chacko Jacob
Gujrathi Sheila
Cui Jingrong Jean
GSK plc
Chen Bihua
Cormorant Asset Management, LP
OrbiMed Capital GP VI LLC
OrbiMed Advisors LLC
Lu Hongbo
Li Yishan
Terms | Privacy | Guide
tony@aum13f.com